Development and Validation Clinician and Patient Reported Photonumeric Scales to Assess Buttocks Cellulite Severity

被引:15
|
作者
Cohen, Joel L. [1 ,2 ]
Sadick, Neil S. [3 ]
Kirby, M. Todd [4 ]
McLane, Michael P. [4 ]
Lenderking, William R. [5 ]
Bender, Randall H. [5 ,6 ]
Chen, Jun [5 ]
Hurley, David [4 ]
Knoble, Naomi B. [5 ]
Liu, Genzhou [4 ]
Xiang, Qinfang [4 ]
Davidson, Jeffrey A. [4 ]
Goldman, Mitchel P. [7 ,8 ]
机构
[1] AboutSkin Dermatol & DermSurg PC, 5340 South Quebec St,Suite 300, Greenwood Village, CO 80111 USA
[2] Univ Calif Irvine, Dermatol, Irvine, CA USA
[3] Cornell Univ, Dept Dermatol, Weill Cornell Med Coll, New York, NY 10021 USA
[4] Endo Pharmaceut Inc, Malvern, PA USA
[5] Evidera, Bethesda, MD USA
[6] Univ N Carolina, Dept Anesthesiol, Chapel Hill, NC 27515 USA
[7] Cosmet Laser Dermatol, San Diego, CA USA
[8] Univ Calif San Diego, Dermatol, San Diego, CA 92103 USA
关键词
D O I
10.1097/DSS.0000000000002756
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
BACKGROUND The Clinician Reported Photonumeric Cellulite Severity Scale (CR-PCSS) and Patient Reported PCSS (PR-PCSS) are newly developed tools for assessing cellulite severity. OBJECTIVE To report on the reliability, validity, and ability to detect a change in cellulite severity on the buttocks of adult women with the CR-PCSS and PR-PCSS. MATERIALS AND METHODS Content validity of both scales was established through concept elicitation and cognitive interviews. Test-retest reliability was evaluated, and intra-rater (both scales) and inter-rater (CR-PCSS only) reliability were estimated using intraclass correlation coefficients (ICCs) for agreement and consistency. Ability to detect a change was determined using the Subject-Global Aesthetic Improvement Scale (GAIS) or Investigator-GAIS as anchors. RESULTS For the CR-PCSS (n = 6) at baseline and Day 2, the mean interrater ICCs were $0.70 and mean intrarater ICCs (95% confidence interval [CI]) were $0.81 (0.72-0.90) for both buttocks. For the PR-PCSS (n = 99) at baseline and Day 14, the mean test-retest reliability ICCs (95% CI) were $0.86 (0.79-0.91) for both buttocks. A clinically meaningful change was 1.0 point on the PR-PCSS and 1.0 on the CR-PCSS. CONCLUSION The CR-PCSS and PR-PCSS reliably assess cellulite severity of the buttocks and can detect a clinically meaningful change after treatment for cellulite.
引用
收藏
页码:1628 / 1635
页数:8
相关论文
共 50 条
  • [21] Development and Initial Validation of a Novel System to Assess Ichthyosis Severity
    Sun, Qisi
    Asch, Sarah
    Bayart, Cheryl
    Bayliss, Susan J.
    Benjamin, Latanya
    Bruckner, Anna
    DiGiovanna, John J.
    Fleckman, Philip
    Funk, Tracy
    Lucky, Anne
    Nelson, Caroline A.
    Newell, Brandon
    Polcari, Ingrid
    Teng, Joyce
    Williams, Mary L.
    Gan, Geliang
    Deng, Yanhong
    Paller, Amy S.
    Choate, Keith A.
    JAMA DERMATOLOGY, 2022, 158 (04) : 359 - 365
  • [22] Development and validation of patient reported outcomes measurement scales for Crohn's disease: The inflammatory bowel disease impact and symptom scales (IBDIMSYS)
    Rauchensteiner, S.
    Miltenburger, C.
    Schaefer, M.
    VALUE IN HEALTH, 2007, 10 (06) : A359 - A359
  • [23] Development and Content Validation of Novel Patient-Reported Outcome Measures to Assess Disease Severity and Change in Patients with Erythropoietic Protoporphyria: The EPP Impact Questionnaire (EPIQ)
    Mathias, Susan
    Burke, Laurie
    Colwell, Hilary H.
    Mensing, George
    Savage, Will
    Naik, Hetanshi
    PATIENT-RELATED OUTCOME MEASURES, 2024, 15 : 17 - 30
  • [24] Gastroparesis Cardinal Symptom Index (GCSI): Development and validation of a patient reported assessment of severity of gastroparesis symptoms
    Dennis A. Revicki
    Anne M. Rentz
    Dominique Dubois
    Peter Kahrilas
    Vincenzo Stanghellini
    Nicholas J. Talley
    Jan Tack
    Quality of Life Research, 2004, 13 : 833 - 844
  • [25] Gastroparesis Cardinal Symptom Index (GCSI): Development and validation of a patient reported assessment of severity of gastroparesis symptoms
    Revicki, DA
    Rentz, AM
    Dubois, D
    Kahrilas, P
    Stanghellini, V
    Talley, NJ
    Tack, J
    QUALITY OF LIFE RESEARCH, 2004, 13 (04) : 833 - 844
  • [26] Validation of patient-reported global severity of atopic dermatitis in adults
    Vakharia, P. P.
    Chopra, R.
    Sacotte, R.
    Patel, N.
    Immaneni, S.
    White, T.
    Kantor, R.
    Hsu, D. Y.
    Silverberg, J. I.
    ALLERGY, 2018, 73 (02) : 451 - 458
  • [27] Development and Validation of a Disease-Specific Questionnaire to Assess Patient-Reported Symptoms in Polycystic Liver Disease
    Neijenhuis, Myrte K.
    Gevers, Tom J. G.
    Hogan, Marie C.
    Kamath, Patrick S.
    Wijnands, Titus F. M.
    van den Ouweland, Ralf C. P. M.
    Edwards, Marie E.
    Sloan, Jeff A.
    Kievit, Wietske
    Drenth, Joost P. H.
    HEPATOLOGY, 2016, 64 (01) : 151 - 160
  • [28] DEVELOPMENT AND VALIDATION OF A PATIENT-REPORTED QUESTIONNAIRE TO ASSESS THE QUALITY OF LIFE OUTCOMES OF INDIAN BREAST CANCER PATIENTS
    Deshpande, P.
    Chittkathopottamal, A. N.
    Bommareddy, L. S.
    Mallasamy, S.
    VALUE IN HEALTH, 2012, 15 (04) : A236 - A236
  • [29] Beyond frequency and severity - Development and validation of the Brief Coercion and Conflict Scales
    Cook, Sarah L.
    Goodman, Lisa A.
    VIOLENCE AGAINST WOMEN, 2006, 12 (11) : 1050 - 1072
  • [30] DEVELOPMENT AND VALIDATION OF THE NEWCASTLE PATIENT REPORTED ASCITES MEASURE
    Orr, J.
    Hudson, M.
    Jones, D.
    GUT, 2014, 63 : A186 - A186